Clinical Trials

Generative AI Transforms Mental Health Support and Safety
Tech & Innovation Generative AI Transforms Mental Health Support and Safety

The traditional boundaries of psychological intervention are shifting rapidly as digital platforms move away from the restrictive, pre-scripted responses of the past toward highly sophisticated generative models that mimic human cognition. In a world where nearly a quarter of the global population

Scientists Map a Permanent Immune Reservoir in Human Lungs
Tech & Innovation Scientists Map a Permanent Immune Reservoir in Human Lungs

The respiratory tract serves as the primary gateway for a vast array of pathogens, yet the mechanics of how the human body maintains its long-term vigilance within this delicate environment have remained partially obscured until now. Recent breakthroughs from the La Jolla Institute for Immunology

Can Selpercatinib Redefine Treatment for All Solid Tumors?
Research & Development Can Selpercatinib Redefine Treatment for All Solid Tumors?

The emergence of targeted therapies has fundamentally altered the trajectory of modern cancer care, yet few developments have resonated as strongly as the recent full regulatory approval of selpercatinib for adult and pediatric patients. This landmark decision by the FDA signals a profound shift in

Imugene’s Azer-cel Shows Promise in Resistant Lymphoma
Research & Development Imugene’s Azer-cel Shows Promise in Resistant Lymphoma

The clinical landscape of modern oncology is undergoing a profound transformation as biotechnology firms successfully engineer specialized immune cells to target and eliminate aggressive blood cancers that have developed a resistance to conventional medical interventions. Imugene Limited, a

Can a New Chemical Warhead Make Cancer Drugs Safer?
Research & Development Can a New Chemical Warhead Make Cancer Drugs Safer?

Modern oncology is currently witnessing a paradigm shift where the brute force of systemic chemotherapy is being replaced by sophisticated molecular delivery systems designed to spare healthy tissue. While traditional treatments often ravage the entire body to reach a localized tumor, the

Laminar Pharma Completes Pivotal Glioblastoma Clinical Trial
Research & Development Laminar Pharma Completes Pivotal Glioblastoma Clinical Trial

The persistent challenge of treating glioblastoma multiforme has long remained one of the most formidable frontiers in modern oncology due to the aggressive nature of these tumors and the restrictive blood-brain barrier. For decades, the standard of care has relied heavily on surgical resection

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later